Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

• Moses Badio,
• Edouard Lhomme,
• Mark Kieh,
• Abdoul Habib Beavogui,
• Stephen B. Kennedy,
• Seydou Doumbia,
• Bailah Leigh,
• Samba O. Sow,
• Alpha Diallo,
• Daniela Fusco,
• Matthew Kirchoff,
• Monique Termote,
• Renaud Vatrinet,
• Deborah Wentworth,
• Helène Esperou,
• H. Clifford Lane,
• Jerome Pierson,
• Deborah Watson-Jones,
• Céline Roy,
• Eric D’Ortenzio,
• Brian Greenwood,
• Genevieve Chêne,
• Laura Richer,
• James D. Neaton,
• Yazdan Yazdanpanah,
• the PREVAC study team

Affiliations

Moses Badio

Partnership for Research on Ebola Virus in Liberia (PREVAIL)

Edouard Lhomme

Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform

Mark Kieh

Partnership for Research on Ebola Virus in Liberia (PREVAIL)

Abdoul Habib Beavogui

Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah

Stephen B. Kennedy

Partnership for Research on Ebola Virus in Liberia (PREVAIL)

Seydou Doumbia

University of Sciences, Technique and Technology of Bamako

Bailah Leigh

College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone

Samba O. Sow

Centre pour le Développement des Vaccins

Alpha Diallo

INSERM, Pôle de Recherche Clinique

Daniela Fusco

INSERM, Pôle de Recherche Clinique

Matthew Kirchoff

National Institute of Allergy and Infectious Diseases

Monique Termote

Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform

Renaud Vatrinet

REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm

Deborah Wentworth

Division of Biostatistics, School of Public Health, University of Minnesota

Helène Esperou

INSERM, Pôle de Recherche Clinique

H. Clifford Lane

National Institute of Allergy and Infectious Diseases

Jerome Pierson

National Institute of Allergy and Infectious Diseases

Deborah Watson-Jones

London School of Hygiene & Tropical Medicine

Céline Roy

Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform

Eric D’Ortenzio

REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm

Brian Greenwood

London School of Hygiene & Tropical Medicine

Genevieve Chêne

Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform

Laura Richer

Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform

James D. Neaton

Division of Biostatistics, School of Public Health, University of Minnesota

Yazdan Yazdanpanah

REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm

the PREVAC study team